Radiopharmaceuticals

Medicinal radio compounds, often known as Radiopharmaceuticals, are a class of medications that include radioactive isotopes. Radiopharmaceuticals can be utilised as both therapeutic and diagnostic tools. Unlike contrast media that absorb or change environmental electromagnetic or ultrasound, radiopharmaceuticals produce radiation on their own. The area of pharmacology that focuses on these medications is called Radiopharmacology. The majority of these substances are radiotracers, which are utilised to identify bodily tissue malfunction. Despite the fact that not all medicinal isotopes are radioactive, radiopharmaceuticals are the most traditional and widely used of these medicines. A useful source of ionising radiation, radiopharmaceuticals are bioactive compounds that have been radionuclide-labelled and are primarily used in medical testing and treatment. They must carefully be checked for sterility, apyrogenity, and other quality control characteristics because they are mostly delivered intravenously. In general, short-lived radionuclides generating positrons or -rays are used in diagnostics, whereas Auger electrons, and (electrons) emitters, and (electrons) emitters are used in treatment. In certain rare instances, the same element or even the same radionuclide (such as 131 is used for both diagnostic and therapeutic reasons (for example, the diagnostics Radioisotope 64Cu and the therapeutic radionuclide 67Cu). Very tiny amounts (nano to pico-molar range) of the radiotracer are perfused into the human body quickly and painlessly during Radio diagnostic imaging.